Form 4: DBV Technologies' Chief Medical Officer Sells Shares
SEC Form 4 Filing
Pharis Mohideen, Chief Medical Officer of DBV Technologies S.A., sold a total of 1,042 ordinary shares in two transactions on May 22 and May 24, 2024.
Summary
- Pharis Mohideen, the Chief Medical Officer of DBV Technologies S.A., reported the sale of company shares.
- On May 22, 2024, 382 ordinary shares were sold at a price of $1.38 per share.
- On May 24, 2024, 660 ordinary shares were sold at a price of $1.36 per share.
- Following these transactions, Mohideen directly owns 81,152 ordinary shares.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock sales by an officer. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common for executives of publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The sale of shares by a company officer could be perceived negatively by some shareholders, although the impact is likely minimal given the relatively small number of shares sold.
Key Dates
| Date | Description |
|---|---|
| 05/22/2024 | Sale of 382 ordinary shares at $1.38 per share. |
| 05/24/2024 | Sale of 660 ordinary shares at $1.36 per share. |
| 05/29/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.